This inventor holds 3 USPTO granted patents. Top assignees: Chong Kun Dang Corporation, Dong-A Pharmaceutical Co., Ltd. Active years: 1994-2001.
Company Filing History:
Years Active: 1994-2001
Title: Kwang Dae Ok: Innovator in Camptothecin Compounds
Introduction
Kwang Dae Ok is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of camptothecin compounds. With a total of 3 patents, his work has focused on enhancing the efficacy and solubility of these important compounds.
Latest Patents
Kwang Dae Ok's latest patents include innovative methods related to camptothecin compounds. One of his notable patents is for camptothecin derivatives and pharmaceutically acceptable salts thereof, along with their manufacturing methods. These derivatives are modified in the B-ring and E-ring, resulting in improved water solubility and enhanced antineoplastic effects. Additionally, he has developed intermediates for the synthesis of camptothecin derivatives, which are crucial for the production of these compounds.
Career Highlights
Throughout his career, Kwang Dae Ok has worked with prominent companies in the pharmaceutical industry. He has been associated with Chong Kun Dang Corporation and Dong-A Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to contribute significantly to the advancement of pharmaceutical innovations.
Collaborations
Kwang Dae Ok has collaborated with esteemed colleagues, including Sang Sup Jew and Hee Soon Lee. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.
Conclusion
Kwang Dae Ok is a distinguished inventor whose work on camptothecin compounds has made a significant impact in the pharmaceutical industry. His innovative approaches and collaborations have paved the way for advancements in cancer treatment.